Trump Administration Takes Aim at Health AI Coalition as Key Members Exit

A significant industry group shaping artificial intelligence use in healthcare is facing mounting challenges as the Trump administration intensifies criticism against what it calls a “regulatory cartel.” The Coalition for Health AI (CHAI), which boasts approximately 3,000 members including major technology and healthcare organizations, is seeing key founding partners reconsider their involvement.

Amazon, one of the coalition’s four founding industry partners, has decided not to renew its membership. Meanwhile, Microsoft is conducting an assessment of its continued participation. While neither company explicitly connected these decisions to the administration’s opposition, the timing coincides with increased political scrutiny of the organization.

CHAI has established itself as a prominent advocate for increased AI regulation and transparency in healthcare. Its membership includes influential organizations like Google, OpenAI, and Mayo Clinic. The coalition has pushed for greater oversight regarding how AI tools are tested and deployed in healthcare settings.

The Trump administration has taken an increasingly antagonistic stance toward the group, with officials arguing against allowing industry players to function as self-regulatory bodies. This represents a broader ideological shift in how the administration approaches technology regulation, particularly in sensitive areas like healthcare.

Medicare Advantage Insurers Face Scrutiny Over AI Use

In a related development, Senator Richard Blumenthal (D-Conn.) is pressing major Medicare Advantage insurers for greater transparency regarding their artificial intelligence implementations. The senator has sent letters to executives at UnitedHealth Group, Humana, and CVS Health (owner of Aetna) requesting detailed information about their AI practices.

Blumenthal’s inquiry follows a Senate subcommittee report that revealed a troubling pattern: payment denials for seriously ill patients increased significantly after these insurers began implementing AI and predictive analytics tools in their coverage decision processes. The senator is seeking clarity on how these systems function and their impact on patient care.

This investigation highlights growing concerns about algorithmic accountability in healthcare decision-making, particularly when such systems affect vulnerable populations like Medicare beneficiaries.

California Establishes First Legal Definition for Ultra-Processed Foods

California has become the first state to legally define “ultra-processed foods” through legislation aimed at improving school lunch nutrition. Governor Gavin Newsom signed a bill Wednesday that creates a formal definition for these controversial food products, which have been linked to various health concerns.

The new law defines ultra-processed foods as products containing both high levels of sodium, added sugar, or saturated fat, along with additives such as stabilizers, emulsifiers, and artificial flavors. California’s health department will further refine the definition of “ultra-processed foods of concern” based on scientific evidence and existing restrictions.

Schools across the state will be required to phase out products meeting this definition over the next decade, marking a significant shift in nutritional policy for educational institutions.

At the federal level, Health Secretary Robert F. Kennedy Jr. and Agriculture Secretary Brooke Rollins announced plans this summer to develop a national definition for ultra-processed foods, though no timeline has been established for implementation.

Controversy Surrounds Health Secretary’s Claims on Circumcision and Autism

During a Cabinet meeting Thursday, Health Secretary Robert F. Kennedy Jr. made controversial claims suggesting that circumcised children have “double the rates of autism” and speculated about a connection to acetaminophen (Tylenol) use.

Public health experts note that these assertions lack scientific support. The limited research examining potential connections between circumcision and autism has not established a robust association, let alone the causal relationship suggested by the secretary.

Kennedy further claimed that studies investigating prenatal acetaminophen use consistently show “profound neurological and behavioral changes” linked to autism. However, scientific consensus does not support this characterization of the evidence.

These statements reflect ongoing tensions between the administration’s health messaging and established medical consensus. A recent KFF poll indicates that 62% of Americans disapprove of the secretary’s handling of vaccine policy, suggesting declining public confidence in the administration’s health guidance.

As AI continues reshaping healthcare delivery and decision-making, the conflict between industry self-regulation and government oversight represents a critical policy battleground with far-reaching implications for patients, providers, and the healthcare technology sector.